Lifevantage (NASDAQ:LFVN) Stock Passes Above 200 Day Moving Average – Here’s Why

Lifevantage Corporation (NASDAQ:LFVN)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $5.71 and traded as high as $6.31. Lifevantage shares last traded at $6.25, with a volume of 125,559 shares.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Weiss Ratings upgraded Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Lake Street Capital downgraded shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target on the stock. in a research report on Thursday, May 7th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $5.00.

Lifevantage Price Performance

The stock’s 50 day moving average is $6.70 and its two-hundred day moving average is $5.72. The firm has a market capitalization of $78.72 million, a P/E ratio of 13.87 and a beta of 0.73.

Lifevantage (NASDAQ:LFVN) last released its earnings results on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). The business had revenue of $43.72 million for the quarter, compared to analyst estimates of $47.77 million. Lifevantage had a return on equity of 23.89% and a net margin of 2.94%. As a group, equities research analysts expect that Lifevantage Corporation will post 0.6 EPS for the current year.

Lifevantage Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 3.2%. This is an increase from Lifevantage’s previous quarterly dividend of $0.04. The ex-dividend date was Monday, June 1st. Lifevantage’s dividend payout ratio (DPR) is 44.44%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of LFVN. Jane Street Group LLC increased its stake in Lifevantage by 5.4% in the first quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock valued at $533,000 after purchasing an additional 1,877 shares in the last quarter. Cetera Investment Advisers boosted its position in shares of Lifevantage by 10.8% during the second quarter. Cetera Investment Advisers now owns 20,098 shares of the company’s stock worth $263,000 after purchasing an additional 1,954 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Lifevantage by 11.9% in the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after buying an additional 3,571 shares during the period. Invesco Ltd. grew its holdings in shares of Lifevantage by 13.6% in the 4th quarter. Invesco Ltd. now owns 30,085 shares of the company’s stock valued at $185,000 after buying an additional 3,603 shares during the period. Finally, JPMorgan Chase & Co. increased its position in shares of Lifevantage by 870.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after buying an additional 4,499 shares in the last quarter. Institutional investors and hedge funds own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.